← Eichor
Condition: Pediatric Bronchiolitis Obliterans Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pediatric Bronchiolitis Obliterans

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT07354074A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Di
Phase 2 · 41 location(s) · Incyte Corporation · NCT07124078Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
EARLY_Phase 1 · 1 location(s) · Regend Therapeutics · NCT07239895TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Phase N/A · 9 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04098445
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.